000 01588 a2200457 4500
005 20250514181746.0
264 0 _c20040402
008 200404s 0 0 eng d
022 _a0021-972X
024 7 _a10.1210/jc.2003-031231
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavis, Mark E
245 0 0 _aUrocortin-1 infusion in normal humans.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cMar 2004
300 _a1402-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenocorticotropic Hormone
_xblood
650 0 4 _aAdult
650 0 4 _aBlood Pressure
650 0 4 _aCorticotropin-Releasing Hormone
_xadministration & dosage
650 0 4 _aCross-Over Studies
650 0 4 _aGhrelin
650 0 4 _aHeart Rate
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xblood
650 0 4 _aKidney
_xphysiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPeptide Hormones
_xmetabolism
650 0 4 _aPituitary Gland, Anterior
_xdrug effects
650 0 4 _aUrocortins
700 1 _aPemberton, Chris J
700 1 _aYandle, Timothy G
700 1 _aLainchbury, John G
700 1 _aRademaker, Miriam T
700 1 _aNicholls, M Gary
700 1 _aFrampton, Christopher M
700 1 _aRichards, A Mark
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 89
_gno. 3
_gp. 1402-9
856 4 0 _uhttps://doi.org/10.1210/jc.2003-031231
_zAvailable from publisher's website
999 _c14721832
_d14721832